Propantheline and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Propantheline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can slow down your gut and bladder. Buprenorphine is an opioid pain and addiction medicine, and opioids are well known for causing constipation. Propantheline is an anticholinergic, which also slows the muscles that move stool through your intestines and empty your bladder.
When you take them together, those effects can add up. In rare cases the gut can slow so much that it nearly stops, which is called paralytic ileus, and you may also have trouble urinating. This is a theoretical concern, so it may never happen to you. Watch for bad constipation, belly bloating, or trouble peeing, and let your care team know. They can manage this easily.
Additive PD interaction reducing GI and urinary motility. Buprenorphine (mu-opioid agonist) and propantheline (antimuscarinic anticholinergic) both decrease gastric and bowel motility and can impair bladder emptying. Combined use may worsen constipation and urinary retention, with a theoretical risk of paralytic ileus.
- Direction: additive, increases anticholinergic/opioid GI and urinary effects.
- Evidence: theoretical; severity rated major.
- Onset: unspecified.
- Monitoring: assess bowel function, abdominal distension, and urinary retention.
- Management: consider prophylactic bowel regimen; individualize dosing and monitor more closely.
What happens
An increased risk of paralytic ileus
Interaction Deep Dive
Using buprenorphine together with an anticholinergic drug can lead to urinary retention or severe constipation that progresses to paralytic ileus. When these two are taken at the same time, watch patients for indications of urinary retention or decreased gastric motility1.
Why it happens (mechanism)
Additive effects on gastric motility
How to manage this interaction
The good news: your care team can manage this. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for constipation and trouble urinating, and doses may need to be adjusted and individualized.
- Tell your pharmacist or prescriber right away if you have severe constipation, a bloated or painful belly, no bowel movements for several days, vomiting, or trouble passing urine.
- Ask whether a stool softener, laxative, or extra fluids and fiber would be helpful for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Propantheline and Buprenorphine together?
Taking buprenorphine and propantheline together can add up to worse constipation and urinary retention, with a rare theoretical risk of paralytic ileus. Keep taking both as prescribed and tell your care team about severe constipation, belly bloating, or trouble urinating. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Propantheline and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Propantheline and Buprenorphine interaction managed?
The good news: your care team can manage this. Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for constipation and trouble urinating, and doses may need to be adjusted and individualized. Tell your pharmacist or prescriber right away if you have severe constipation, a bloated or painful belly, no bowel movements f… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Propantheline or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
Keep reading about Buprenorphine
Keep reading about Propantheline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist